Oligonucleotide Therapeutics: From Discovery and Development to Patentability

Following the first proof of concept of using small nucleic acids to modulate gene expression, a long period of maturation led, at the end of the last century, to the first marketing authorization of an oligonucleotide-based therapy. Since then, 12 more compounds have hit the market and many more ar...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Lara Moumné, Anne-Céline Marie, Nicolas Crouvezier
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	MDPI AG 2022-01-01
Edice:	Pharmaceutics
Témata:	oligonucleotides antisense small interfering RNA exon skipping small activating RNA microRNA
On-line přístup:	https://www.mdpi.com/1999-4923/14/2/260
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!